{
  "id": 4898,
  "text": "[83] CIOMS Working Groups.Guidelines for Preparing Core Clin￣ ical￣Safety Information on Drugs [ M / OL].[ 2020￣ 11￣ 26].https: / / cioms.ch / wp￣content / uploads / 2018 / 03 / Guidelines￣ for￣Preparing￣Core￣Clinical￣Safety￣Info￣Drugs￣Report￣of￣CI￣ OMS￣Working￣Group￣Ⅲ￣and￣Ⅴ.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: [83] CIOMS Working Groups.Guidelines for Preparing Core Clin￣ ical￣Safety Information on Drugs [ M / OL].[ 2020￣ 11￣ 26].https: / / cioms.ch / wp￣content / uploads / 2018 / 03 / Guidelines￣ for￣Preparing￣Core￣Clinical￣Safety￣Info￣Drugs￣Report￣of￣CI￣ OMS￣Working￣Group￣Ⅲ￣and￣Ⅴ.\n\n<question>: ",
  "ChatGPT_response_0": "在CIOMS关于药物的核心临床安全信息准备指南中，有几个重要的步骤和关键要点需要特别注意。首先，应当确保收集到的数据详尽全面，包括针对严重不良事件和特定人群的信息。其次，对于药物的不良反应和副作用，需要进行详细的描述和分类，以便医疗专业人员和患者能够准确了解。此外，还需要对药物性质、给药途径、用药剂量等方面进行充分的说明，以确保患者安全使用药物。最后，在准备核心临床安全信息时，应当严格遵循CIOMS的指南和标准，确保信息的可靠性和准确性。这些步骤和要点对于提供合格的临床安全信息至关重要。",
  "query": "在CIOMS关于药物的核心临床安全信息准备指南中，有哪些重要的步骤或关键要点需要特别注意？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在CIOMS关于药物的核心临床安全信息准备指南中，有哪些重要的步骤或关键要点需要特别注意？\n\n<reference text>: [83] CIOMS Working Groups.Guidelines for Preparing Core Clin￣ ical￣Safety Information on Drugs [ M / OL].[ 2020￣ 11￣ 26].https: / / cioms.ch / wp￣content / uploads / 2018 / 03 / Guidelines￣ for￣Preparing￣Core￣Clinical￣Safety￣Info￣Drugs￣Report￣of￣CI￣ OMS￣Working￣Group￣Ⅲ￣and￣Ⅴ.\n\n<reply>: ",
  "response": "在CIOMS关于药物的核心临床安全信息准备指南中，有几个重要的步骤和关键要点需要特别注意。首先，应当确保收集到的数据详尽全面，包括针对严重不良事件和特定人群的信息。其次，对于药物的不良反应和副作用，需要进行详细的描述和分类，以便医疗专业人员和患者能够准确了解。此外，还需要对药物性质、给药途径、用药剂量等方面进行充分的说明，以确保患者安全使用药物。最后，在准备核心临床安全信息时，应当严格遵循CIOMS的指南和标准，确保信息的可靠性和准确性。这些步骤和要点对于提供合格的临床安全信息至关重要。"
}